Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Triple class refractory multiple myeloma

Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA
Triple class refractory multiple myeloma ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
10 Nov 2021

Managing immune-related adverse effects in Africa

Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya
Managing immune-related adverse effects in Africa ( Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya )
10 Nov 2021

Palliative care in Africa

Dr Christian Ntizimira Ruchaho - Rwanda Palliative and Hospice Organisation, Kigali City, Rwanda
Palliative care in Africa ( Dr Christian Ntizimira Ruchaho - Rwanda Palliative and Hospice Organisation, Kigali City, Rwanda )
8 Nov 2021

Managing high-risk/MRD positive and standard-risk/MRD myeloma

Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021

Minimum residual disease techniques in myeloma

Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Minimum residual disease techniques in myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021

Rescue after daratumumab failure

Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA
Rescue after daratumumab failure ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
26 Oct 2021

Programme topics at AORTIC 2021 virtual

Dr Abubakar Bello - National Hospital, Abuja, Nigeria
Programme topics at AORTIC 2021 virtual ( Dr Abubakar Bello - National Hospital, Abuja, Nigeria )
19 Oct 2021

Pathogenesis of colon adenocarcinoma in Kerala, India

Dr Prasanth Ariyannur - Amrita Institute of Medical Sciences and Research Center, Kochi India
Pathogenesis of colon adenocarcinoma in Kerala, India ( Dr Prasanth Ariyannur - Amrita Institute of Medical Sciences and Research Center, Kochi India )
12 Oct 2021

ESMO 2021: Latest in EGFR mutated advanced NSCLC

Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera
ESMO 2021: Latest in EGFR mutated advanced NSCLC ( Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera )
11 Oct 2021

First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA

Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA ( Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA )
6 Oct 2021

Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastatic breast cancer

Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastatic breast cancer ( Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain )
30 Sep 2021

ESMO 2021: PARPi data and their role in mono/combination therapies

Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong
ESMO 2021: PARPi data and their role in mono/combination therapies ( Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong )
29 Sep 2021